Immunohistochemical MUC1 (DF3 antigen) expression of human esophageal squamous cell-carcinoma

Anticancer Research

Volumn 21, Issue 2 B, 2001, Pages 1285-1289

  Kijima, H ^a   Chino, O ^a   Oshiba, G ^a   Tanaka, H ^a   Kenmochi, T ^a   Kise, Y ^a   Shimada, H ^a   Abe, Y ^a   Tokunaga, T ^a   Yamazaki, H ^a   Nakamura, M ^a   Tanaka, M ^a   Makuuchi, H ^a   Ueyama, Y ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DF3; Esophagus; Immunohistochemistry; MUC1; Squamous cell carcinoma

Indexed keywords

GLYCOPROTEIN; MUCIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA;

AGED; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED;

EID: 0035017419     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors
2. Distribution of carcinoma antigens CA19-9 and CA15-3
3. Immunoelectron microscopic localization of DF3 cancer-associated antigen in human breast cancer
4. Reactivity of monoclonal antibody DF-3 with a high molecular weight antigen expressed in human ovarian carcinomas
5. Expression of the DF-3-P epitope in human ovarian carcinomas
6. Expression of mucin 1 (MUC1) in esophageal squamous-cell carcinoma: Its relationship with prognosis
7. Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patient
8. Prognostic significance of MUC1 epithelial mucin expression in breast cancer
9. Bcl-2 and p53 immunophenotypes in pre-invasive, early and advanced oesophageal squamous cancer
10. Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis
11. Carcinogenesis and histogenesis of esophageal carcinoma
12. Histological classification of oesophageal tumors
13. Treatment of esophageal cancer in patients over 80 years old
14. Clinical pathological analysis of surgically resected superficial esophageal carcinoma to determine criteria for deciding on treatment strategy
15. Frequent expression of inducible nitric oxide synthase in esophageal squamous cell carcinomas
16. Stromal thrombospondin-1 expression is correlated with progression of esophageal squamous cell carcinomas
17. Stromal CEA immunoreactivity is correlated with lymphatic invasion of human esophageal carcinoma. Thrombospondin-1 expression is correlated with progression of esophageal squamous cell carcinomas
18. Oesophagus
19. Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration
20. Stromal expression of thrombospondin-1 (TSP1) is correlated with growth and metastasis of human gallbladder carcinoma
21. DF3 expression in human gallbladder carcinoma: Its significance for lymphatic invasion
22. Comparison of sialyl-Levis a-carrying CD43 and MUC1 mucins secreted from a colon carcinoma cell line for E-selectin binding and inhibition of leukocyte adhesion
23. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellar matrix components
24. Effect of MUC1 mucin, an anti-adhesional molecule, on tumor cell growth
25. Increased invasiveness of MUC1 and cDNA-transfected human gastric cancer MKN74 Cells
26. Expression of MUC1 and MUC2 mucins in gastric carcinomas: Its relationship with prognosis of the patients
27. Immunoreactive MUC1 expression at the deepest invasive portion: Correlation with prognosis of colorectal cancer
28. MUC1 expression in intramucosal colorectal neoplasms
29. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histochemical subtype and prognosis of gastric carcinomas